Clinical trial
LISTEN: Supporting Communication in Patients With Tumor-Related Aphasia
NCT07732140 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LISTEN: Supporting Communication in Patients With Tumor-Related Aphasia
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- December 31, 2030
- Enrollment
- 80 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
aphasia, malignant brain tumor